Reveal HealthTech, an AI transformation partner for healthcare and life sciences organisations in the US, has announced that it has secured $7.2 million in Series A funding. The
Reveal HealthTech, an AI transformation partner for healthcare and life sciences organisations in the US, has announced that it has secured $7.2 million in Series A funding. The round was led by Leo Capital with additional participation from Sanos Capital.
Founded in 2023 and incubated by W Health Ventures and 2070 Health, the company works with healthcare organisations to identify their most pressing challenges and build safe, clinically relevant AI systems to address them.
The new funding will be used to expand Reveal’s solution portfolio, strengthen its sales network, and extend its reach to healthcare and life sciences leaders globally.
“Our mission is simple but bold,” said Sanchit Mullick, Founder of Reveal HealthTech. “We want to make AI the most trusted and accountable partner in healthcare, driving breakthroughs for everyone from Fortune 100 pharma companies and large healthcare delivery systems to emerging innovators in digital health.”
Reveal’s solutions focus on creating measurable customer value while improving operational profitability. Its flagship offerings include:
Dr. Sumir Sahgal, founder and Chief Medical Officer of Essen Health Care, a New York-based fully integrated healthcare delivery network, praised the company’s ability to blend empathy with intelligence in care delivery.
“Every year, across hundreds of thousands of patient touchpoints, we’ve seen the profound impact that compassion and intelligence can have when woven into care. With Reveal, that vision is becoming reality,” Dr. Sahgal said. “By acting on data in real-time, we’re not only improving patient experiences but also easing the burden on clinicians.”
With this investment, Reveal HealthTech aims to strengthen its role as a trusted AI partner for healthcare providers, life sciences companies, and digital health innovators. By combining advanced AI systems with clinical safety and accountability, the startup seeks to transform patient outcomes, accelerate research, and optimise healthcare operations on a global scale.
